JMP Securities analyst, David Turkaly, lowered the price target on Integra LifeSciences (NASDAQ: IART) to $62.00 (from $66.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Integra LifeSciences (IART) PT Lowered to $60 at CitiNovember 2, 2018 7:12 AM Integra LifeSciences (IART) PT Lowered to $58 at RBC CapitalNovember 1, 2018 6:41 AM Integra LifeSciences (IART) PT Lowered to $55 at Wells FargoOctober 31, 2018 3:57 PM Integra LifeSciences (IART) Reports In-Line Q3 EPS, Revenues Miss; Raises FY18 Revenue Outlook, Maintains FY18 EPS GuidanceOctober 31, 2018 6:13 AM Integra LifeSciences Reports Third Quarter 2018 Financial ResultsOctober 31, 2018 6:00 AM